TXNIP and type 2 diabetes mellitus: Third, TXNIP, which is upregulated in models of β cell dysfunction and T2D (72, 73), binds and sequesters reduced thioredoxin and thereby limits thioredoxin availability for ER redox buffering (74, 75).